Geneva Capital Management’s Hamilton Lane HLNE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$11.7M Sell
148,795
-125,899
-46% -$11.2M 0.27% 76
2026
Q1
$27.3M Sell
274,694
-35,655
-11% -$4.38M 0.58% 51
2025
Q4
$41.7M Buy
310,349
+37,689
+14% +$4.74M 0.78% 45
2025
Q3
$36.8M Buy
272,660
+141
+0.1% +$21.3K 0.63% 54
2025
Q2
$38.7M Buy
272,519
+15,262
+6% +$2.3M 0.65% 52
2025
Q1
$38.2M Buy
257,257
+670
+0.3% +$102K 0.71% 49
2024
Q4
$38M Sell
256,587
-2,152
-0.8% -$383K 0.66% 49
2024
Q3
$43.6M Buy
258,739
+63,866
+33% +$9.25M 0.73% 48
2024
Q2
$24.1M Sell
194,873
-3,735
-2% -$437K 0.44% 74
2024
Q1
$22.4M Buy
+198,608
New +$22.4M 0.39% 77

Other funds holding HLNE

Geneva Capital Management's HLNE Position: Q2 2026 in Review

Geneva Capital Management reduced its Hamilton Lane (HLNE) stake by 46% in Q2 2026, selling an estimated $11.2M and leaving 148,795 shares worth $11.7M. The position accounts for 0.27% of the portfolio, ranked #76.

Geneva Capital Management first reported a position in HLNE in Q1 2024 and has held it in 10 quarters since. The position peaked at $43.6M in Q3 2024. 380 funds tracked by Wall St. Rank hold HLNE as of Q2 2026.

  • Geneva Capital Management held 148,795 shares of Hamilton Lane worth $11.7M as of Q2 2026.
  • Geneva Capital Management sold 125,899 Hamilton Lane shares in Q2 2026, an estimated $11.2M.
  • Hamilton Lane made up 0.27% of Geneva Capital Management's portfolio in Q2 2026, its #76 holding.
  • Geneva Capital Management first reported a position in Hamilton Lane in Q1 2024 and has held it in 10 quarters since.
  • Geneva Capital Management's Hamilton Lane position peaked at $43.6M in Q3 2024.
  • 380 funds tracked by Wall St. Rank held Hamilton Lane as of Q2 2026.

Based on Geneva Capital Management's 13F filing for Q2 2026, filed 6 Aug 2026.